Baylor Genetics

Baylor Genetics Baylor Genetics is a joint venture of H.U. Group Holdings and the #1 NIH-funded genetics program at

Baylor Genetics is founded in academics and driven by discovery; we are dedicated to delivering comprehensive answers to the toughest genetic questions.

For patients facing long diagnostic odysseys, genomic technologies are helping deliver clearer answers.At , Christine E...
03/16/2026

For patients facing long diagnostic odysseys, genomic technologies are helping deliver clearer answers.

At , Christine Eng, MD, Chief Medical Officer and Chief Quality Officer, and Chris Sands, Chief Growth Officer of Baylor Genetics, sat down with Kira Dineen of DNA Today to discuss the latest advancements in precision diagnostics, and what they mean for providers and the patients they serve.

This conversation explores how enhancing Whole Genome Sequencing with supplemental technologies—including optical genome mapping, long-read sequencing, and RNA Sequencing—is helping providers gain deeper insight into complex cases, reduce uncertainty, and support more informed care decisions for patients facing long diagnostic odysseys.

Watch or listen now: dnapodcast.com/episodes/2026/3/13/385-inside-acmg-2026

What if your clinical genome test could do more? Today at , we explored exactly what that could look like. In the Exhib...
03/13/2026

What if your clinical genome test could do more? Today at , we explored exactly what that could look like.

In the Exhibit Theatre, Christine Eng, MD, Chief Medical Officer and Chief Quality Officer, and Chris Sands, Chief Growth Officer, discussed how enhanced Whole Genome Sequencing—paired with optical genome mapping, long-read sequencing, and RNA sequencing—can deliver more informed results for the most complex rare disease cases.

Thank you for everyone who joined us and for being part of Baylor Genetics’ commitment to precision diagnostics and putting patients first.

Learn more: https://www.baylorgenetics.com/wgs2026/

Happening today! At , Baylor Genetics takes the stage in the Exhibit Theatre to share how enhanced Whole Genome Sequenc...
03/13/2026

Happening today! At , Baylor Genetics takes the stage in the Exhibit Theatre to share how enhanced Whole Genome Sequencing—supplemented with optical genome mapping, long‑read sequencing, and RNA Sequencing—delivers more informed results for the most complex rare disease cases.

Learn more: https://www.baylorgenetics.com/conferences/acmg-2026/

03/13/2026

If you’re at , swing by booth 1017 to learn about how Baylor Genetics’ multimodal approach can help inform diagnoses and support clinical decision-making for patients with complex rare disease.

We’re looking forward to meeting you!

03/11/2026

Attending ?

Stop by Baylor Genetics’ booth 1017 to learn more about how we’re enhancing Whole Genome Sequencing with optical genome mapping and long-read sequencing, alongside RNA Sequencing, giving deeper resolution for genomic findings such as complex structural variants and short tandem repeats.

If you’re attending the Opening Reception tonight, we’d love to connect! Stop by Baylor Genetics’ booth #1017 to lear...
03/11/2026

If you’re attending the Opening Reception tonight, we’d love to connect!

Stop by Baylor Genetics’ booth #1017 to learn more about how we’re enhancing Whole Genome Sequencing with optical genome mapping and long‑read sequencing, alongside RNA Sequencing, giving deeper resolution for genomic findings such as complex structural variants and short tandem repeats.

Our team will be on site to discuss how a multimodal approach can help inform diagnoses and support clinical decision‑making for patients with complex rare disease.

Learn more: https://www.baylorgenetics.com/conferences/acmg-2026/

Sometimes, answers require going beyond standard sequencing. When deeper insight into the genome is needed, Baylor Genet...
03/11/2026

Sometimes, answers require going beyond standard sequencing.

When deeper insight into the genome is needed, Baylor Genetics’ Whole Genome Sequencing goes even further.

Enabled by advanced technologies—including optical genome mapping and long‑read sequencing—these enhancements give eligible rare disease patients access to additional modalities which include:
- Interpretation of complex structural variants and genomic rearrangements
- Short tandem repeat (STR) analysis across 58 clinically significant genes
- FMR1 methylation analysis for Fragile X syndrome

Visit us at , booth #1017, to learn how we’re unlocking the power of genomics to enable faster, more accurate diagnoses.

Learn more: https://www.baylorgenetics.com/wgs2026/

What if your clinical genome test could do more? We're excited to announce enhancements to our Whole Genome Sequencing (...
03/10/2026

What if your clinical genome test could do more?

We're excited to announce enhancements to our Whole Genome Sequencing (WGS) test with the addition of optical genome mapping (OGM) and long‑read sequencing (LRS) as supplemental technologies.

These advanced technologies—alongside RNA sequencing—enable our WGS test to go beyond standard sequencing approaches, providing a more comprehensive view of a patient’s genome and delivering more answers to help guide patient care and outcomes.

Visit us at , booth 1017, to learn how we’re unlocking the power of genomics to enable faster, more accurate diagnoses: https://www.baylorgenetics.com/news/baylor-genetics-enhances-whole-genome-sequencing-test-with-optical-genome-mapping-and-long-read-sequencing-as-supplemental-technologies/

At , we’re focused on one goal: helping patients and families get answers faster.Shortening the diagnostic odyssey for ...
03/09/2026

At , we’re focused on one goal: helping patients and families get answers faster.

Shortening the diagnostic odyssey for rare and complex disease requires genomic innovation that can truly scale—across technologies, workflows, and the healthcare ecosystem.

To learn more, explore this Fast Company byline from Kengo Takishima, Chairman and CEO of Baylor Genetics, and if you’re attending ACMG, visit us at booth #1017 to see how our multimodal genomic approach delivers deeper insights for complex cases.

https://www.fastcompany.com/91498078/how-to-scale-genomics-to-transform-precision-diagnostics

RNA Sequencing is changing the way we diagnose rare diseases.In this episode of the DNA Today Podcast, host Kira Dineen ...
03/06/2026

RNA Sequencing is changing the way we diagnose rare diseases.

In this episode of the DNA Today Podcast, host Kira Dineen speaks with Dr. Christine Eng, Chief Medical Officer and Chief Quality Officer at Baylor Genetics, about how RNA Sequencing is helping resolve variants of uncertain significance, uncover splicing abnormalities, and shorten the diagnostic odyssey for patients with rare diseases.

“DNA sequencing gives us the blueprint. RNA Sequencing lets us see how that blueprint is actually used.” – Christine Eng, MD

Hear how multiomic approaches are transforming patient care and what the future of rare disease diagnostics looks like. Watch or listen to the full podcast: https://dnapodcast.com/episodes/2026/3/6/384-beyond-dna-how-rnaseq-resolves-vus-and-shortens-the-diagnostic-odyssey

Baylor Genetics is seeking a Senior Genetic Counselor to provide advanced clinical leadership and oversight. In this rol...
03/05/2026

Baylor Genetics is seeking a Senior Genetic Counselor to provide advanced clinical leadership and oversight.

In this role, you’ll manage complex cases, serve as a trusted advisor, and mentor the next generation of genetic counselors.

Join us in helping clinicians and families navigate complex genetic findings with confidence. Apply today: https://recruiting2.ultipro.com/BAY1006BML/JobBoard/0669eed3-5441-4f8e-a7b1-c5df596a4dfe/OpportunityDetail?opportunityId=de25e2c4-4769-48c0-888b-ddd5c9e67038

Address

2450 Holcombe Boulevard
Houston, TX
77021

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 6pm
Saturday 8am - 6pm

Telephone

+18004114363

Website

Alerts

Be the first to know and let us send you an email when Baylor Genetics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Baylor Genetics is a joint venture of Miraca Holdings, Inc. and Baylor College of Medicine, including the #1 NIH-funded Department of Molecular and Human Genetics. A pioneer of precision medicine for nearly 40 years, Baylor Genetics now offers a full spectrum of clinically relevant genetic testing, access to world-renowned experts, and the confidence to provide patients with the best care.

Baylor Genetics, located in Houston’s Texas Medical Center, serves clients in 50 states and 16 countries.